We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LFUS icon
4451
Littelfuse
LFUS
$11B
$656K ﹤0.01%
+4,105
New +$651K
2017 Q1
0 quarters
PRTK
4452
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$656K ﹤0.01%
+34,100
New +$537K
2017 Q1
0 quarters
INSY
4453
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
$656K ﹤0.01%
62,400
-41,400
-40% -$441K
2014 Q2
11 quarters
SAIC icon
4454
PUT
Saic
SAIC
$5.11B
$655K ﹤0.01%
+8,800
New +$748K
2017 Q1
0 quarters
ASRT
4455
CALL
DELISTED
Assertio
ASRT
$654K ﹤0.01%
868
-119
-12% -$121K
2013 Q2
15 quarters
DXJR
4456
DELISTED
WisdomTree Japan Hedged Real Estate Fund
DXJR
$654K ﹤0.01%
+49,105
New +$671K
2017 Q1
0 quarters
MWA icon
4457
Mueller Water Products
MWA
$3.34B
$653K ﹤0.01%
55,278
+3,492
+7% +$44.3K
2015 Q4
5 quarters
PACB icon
4458
Pacific Biosciences
PACB
$845M
$653K ﹤0.01%
126,346
-9,687
-7% -$47.4K
2015 Q3
6 quarters
WPX
4459
PUT
DELISTED
WPX Energy, Inc.
WPX
$653K ﹤0.01%
48,800
-2,800
-5% -$37.4K
2013 Q2
15 quarters
ITM icon
4460
VanEck Intermediate Muni ETF
ITM
$2.09B
$652K ﹤0.01%
+13,919
New +$650K
2017 Q1
0 quarters
LNN icon
4461
PUT
Lindsay Corp
LNN
$1.15B
$652K ﹤0.01%
7,400
-4,500
-38% -$352K
2013 Q2
15 quarters
AROC icon
4462
Archrock
AROC
$5.28B
$650K ﹤0.01%
52,411
-62,810
-55% -$882K
2013 Q2
15 quarters
NNBR icon
4463
NN Inc
NNBR
$332M
$650K ﹤0.01%
+25,804
New +$539K
2017 Q1
0 quarters
PDCO
4464
DELISTED
Patterson Companies, Inc.
PDCO
$650K ﹤0.01%
14,364
-2,404
-14% -$104K
2016 Q4
1 quarter
CDK
4465
CALL
DELISTED
CDK Global, Inc.
CDK
$650K ﹤0.01%
+10,000
New +$640K
2017 Q1
0 quarters
SIVB
4466
DELISTED
SVB Financial Group
SIVB
$650K ﹤0.01%
3,492
-272,248
-99% -$49.5M
2013 Q2
15 quarters
TROX icon
4467
Tronox
TROX
$592M
$649K ﹤0.01%
35,150
-83,383
-70% -$1.24M
2014 Q2
11 quarters
DST
4468
PUT
DELISTED
DST Systems Inc.
DST
$649K ﹤0.01%
10,600
+6,000
+130% +$348K
2013 Q2
15 quarters
RS icon
4469
PUT
Reliance Steel & Aluminium
RS
$20.2B
$648K ﹤0.01%
8,100
-14,100
-64% -$1.16M
2013 Q2
15 quarters
WNC icon
4470
CALL
Wabash National
WNC
$559M
$648K ﹤0.01%
+31,300
New +$613K
2017 Q1
0 quarters
AKRX
4471
CALL
DELISTED
Akorn Inc
AKRX
$648K ﹤0.01%
26,900
+10,900
+68% +$237K
2013 Q2
15 quarters
MTDR icon
4472
PUT
Matador Resources
MTDR
$6.54B
$647K ﹤0.01%
27,200
-23,000
-46% -$575K
2013 Q3
14 quarters
WCC
4473
PUT
WESCO International
WCC
$17.8B
$647K ﹤0.01%
9,300
-1,600
-15% -$112K
2013 Q2
15 quarters
ELLI
4474
DELISTED
Ellie Mae Inc
ELLI
$647K ﹤0.01%
6,454
-88,207
-93% -$8.1M
2013 Q2
15 quarters
UFS
4475
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
$646K ﹤0.01%
17,700
-4,400
-20% -$174K
2016 Q3
2 quarters

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.